Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 298

1.

Increasing incidence of immune-mediated necrotizing myopathy: single-centre experience.

Klein M, Mann H, Pleštilová L, Zámečník J, Betteridge Z, McHugh N, Vencovský J.

Rheumatology (Oxford). 2015 Jun 24. pii: kev229. [Epub ahead of print]

PMID:
26109604
2.

Dr. Vencovský, et al reply.

Vencovský J, Klein M, Mann H.

J Rheumatol. 2015 Jun;42(6):1061. doi: 10.3899/jrheum.150063. No abstract available.

PMID:
26034233
3.

Disease specificity of autoantibodies to cytosolic 5'-nucleotidase 1A in sporadic inclusion body myositis versus known autoimmune diseases.

Herbert MK, Stammen-Vogelzangs J, Verbeek MM, Rietveld A, Lundberg IE, Chinoy H, Lamb JA, Cooper RG, Roberts M, Badrising UA, De Bleecker JL, Machado PM, Hanna MG, Plestilova L, Vencovsky J, van Engelen BG, Pruijn GJ.

Ann Rheum Dis. 2015 Feb 24. pii: annrheumdis-2014-206691. doi: 10.1136/annrheumdis-2014-206691. [Epub ahead of print]

PMID:
25714931
4.

Pro-inflammatory effects of interleukin-35 in rheumatoid arthritis.

Filková M, Vernerová Z, Hulejová H, Prajzlerová K, Veigl D, Pavelka K, Vencovský J, Šenolt L.

Cytokine. 2015 May;73(1):36-43. doi: 10.1016/j.cyto.2015.01.019. Epub 2015 Feb 16.

PMID:
25697137
5.

High levels of metastasis-inducing S100A4 protein and treatment outcome in early rheumatoid arthritis: data from the PERAC cohort.

Šenolt L, Cerezo LA, Šumová B, Pecha O, Pleštilová L, Forejtová Š, Růžičková O, Hušáková M, Závada J, Pavelka K, Vencovský J, Mann H.

Biomarkers. 2015 Feb;20(1):47-51. doi: 10.3109/1354750X.2014.989544. Epub 2014 Dec 9.

PMID:
25489637
6.

The effects of the spleen tyrosine kinase inhibitor fostamatinib on ambulatory blood pressure in patients with active rheumatoid arthritis: results of the OSKIRA-ABPM (ambulatory blood pressure monitoring) randomized trial.

Kitas GD, Abreu G, Jedrychowicz-Rosiak K, Miller JL, Nakov R, Panfilov S, Vencovsky J, Wang M, Weinblatt ME, White WB.

J Am Soc Hypertens. 2014 Nov;8(11):780-90. doi: 10.1016/j.jash.2014.08.013. Epub 2014 Sep 4.

PMID:
25455003
7.

Pregnancy outcome in idiopathic inflammatory myopathy patients in a multicenter study.

Nagy-Vincze M, Vencovsky J, Lundberg IE, Dankó K.

J Rheumatol. 2014 Dec;41(12):2492-4. doi: 10.3899/jrheum.140438. No abstract available.

PMID:
25452187
8.

The metastasis promoting protein S100A4 levels associate with disease activity rather than cancer development in patients with idiopathic inflammatory myopathies.

Pleštilová L, Mann H, Andrés Cerezo L, Pecha O, Vencovský J, Šenolt L.

Arthritis Res Ther. 2014 Oct 31;16(5):468. doi: 10.1186/s13075-014-0468-2.

9.

Expression of BAFF receptors in muscle tissue of myositis patients with anti-Jo-1 or anti-Ro52/anti-Ro60 autoantibodies.

Kryštůfková O, Barbasso Helmers S, Venalis P, Malmström V, Lindroos E, Vencovský J, Lundberg IE.

Arthritis Res Ther. 2014 Oct 10;16(5):454. doi: 10.1186/s13075-014-0454-8.

10.

Genetic diversity among Puccinia melanocephala isolates from Brazil assessed using simple sequence repeat markers.

Peixoto-Junior RF, Creste S, Landell MG, Nunes DS, Sanguino A, Campos MF, Vencovsky R, Tambarussi EV, Figueira A.

Genet Mol Res. 2014 Sep 26;13(3):7852-63. doi: 10.4238/2014.September.26.23.

11.

Therapy of myositis: biological and physical.

Lundberg IE, Vencovsky J, Alexanderson H.

Curr Opin Rheumatol. 2014 Nov;26(6):704-11. doi: 10.1097/BOR.0000000000000109. Review.

PMID:
25198241
12.

A tailored approach to reduce dose of anti-TNF drugs may be equally effective, but substantially less costly than standard dosing in patients with ankylosing spondylitis over 1 year: a propensity score-matched cohort study.

Závada J, Uher M, Sisol K, Forejtová S, Jarošová K, Mann H, Vencovský J, Pavelka K.

Ann Rheum Dis. 2014 Aug 27. pii: annrheumdis-2014-205202. doi: 10.1136/annrheumdis-2014-205202. [Epub ahead of print]

PMID:
25165033
13.

The two mRNA transcription variants of the B-cell activating factor are differentially expressed, but in a stable ratio.

Remakova M, Svitalkova T, Faustova M, Vencovsky J, Novota P, Krystufkova O.

Clin Exp Rheumatol. 2014 Sep-Oct;32(5):763-4. Epub 2014 Aug 15. No abstract available.

PMID:
25152030
14.

OSKIRA-4: a phase IIb randomised, placebo-controlled study of the efficacy and safety of fostamatinib monotherapy.

Taylor PC, Genovese MC, Greenwood M, Ho M, Nasonov E, Oemar B, Stoilov R, Vencovsky J, Weinblatt M.

Ann Rheum Dis. 2014 Jul 29. pii: annrheumdis-2014-205361. doi: 10.1136/annrheumdis-2014-205361. [Epub ahead of print]

PMID:
25074688
15.

Decreased circulating visfatin is associated with improved disease activity in early rheumatoid arthritis: data from the PERAC cohort.

Sglunda O, Mann H, Hulejová H, Kuklová M, Pecha O, Pleštilová L, Filková M, Pavelka K, Vencovský J, Senolt L.

PLoS One. 2014 Jul 28;9(7):e103495. doi: 10.1371/journal.pone.0103495. eCollection 2014.

16.

Tofacitinib versus methotrexate in rheumatoid arthritis.

Lee EB, Fleischmann R, Hall S, Wilkinson B, Bradley JD, Gruben D, Koncz T, Krishnaswami S, Wallenstein GV, Zang C, Zwillich SH, van Vollenhoven RF; ORAL Start Investigators.

N Engl J Med. 2014 Jun 19;370(25):2377-86. doi: 10.1056/NEJMoa1310476.

17.

Genotyping of immune-related genetic variants identifies TYK2 as a novel associated locus for idiopathic inflammatory myopathies.

Jani M, Massey J, Wedderburn LR, Vencovský J, Danko K, Lundberg IE, Padyukov L, Selva-O'Callaghan A, Radstake T, Platt H, Warren RB, Griffiths CE, Lee A, Gregersen PK, Miller FW, Ollier WE, Cooper RG, Chinoy H, Lamb JA; EUMYONET.

Ann Rheum Dis. 2014 Sep;73(9):1750-2. doi: 10.1136/annrheumdis-2014-205440. Epub 2014 May 7. No abstract available.

18.

Arthritis in idiopathic inflammatory myopathy: clinical features and autoantibody associations.

Klein M, Mann H, Pleštilová L, Betteridge Z, McHugh N, Remáková M, Novota P, Vencovský J.

J Rheumatol. 2014 Jun;41(6):1133-9. doi: 10.3899/jrheum.131223. Epub 2014 May 1.

PMID:
24786927
19.

Decrease in serum interleukin-21 levels is associated with disease activity improvement in patients with recent-onset rheumatoid arthritis.

Sglunda O, Mann HF, Hulejová H, Pecha O, Pleštilová L, RůŽičková O, Fojtíková M, Sléglová O, Forejtová S, Pavelka K, Vencovský J, Senolt L.

Physiol Res. 2014 Sep 4;63(4):475-81. Epub 2014 Apr 3.

20.

The metastasis-associated protein S100A4 promotes the inflammatory response of mononuclear cells via the TLR4 signalling pathway in rheumatoid arthritis.

Cerezo LA, Remáková M, Tomčik M, Gay S, Neidhart M, Lukanidin E, Pavelka K, Grigorian M, Vencovský J, Šenolt L.

Rheumatology (Oxford). 2014 Aug;53(8):1520-6. doi: 10.1093/rheumatology/keu031. Epub 2014 Mar 18.

PMID:
24643522
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk